Chronic allograft nephropathy

Pediatric Nephrology

Volumn 24, Issue 8, 2009, Pages 1465-1471

  Fletcher, Jeffery T ^a   Nankivell, Brian J ^a   Alexander, Stephen I ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Chronic allograft nephropathy; CNI; Kidney transplantation; Rejection

Indexed keywords

ALEMTUZUMAB; BELATACEPT; CALCINEURIN INHIBITOR; CIDOFOVIR; CIPROFLOXACIN; CORTICOSTEROID; EVEROLIMUS; FINGOLIMOD; GANCICLOVIR; JANUS KINASE INHIBITOR; LEFLUNOMIDE; RAPAMYCIN; RECOMBINANT OSTEOGENIC PROTEIN 1; RITUXIMAB;

ANTIGEN PRESENTATION; CHRONIC ALLOGRAFT NEPHROPATHY; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DRUG MEGADOSE; DRUG WITHDRAWAL; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR GENETICS; ORGAN DONOR; PATIENT ATTITUDE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; VIRUS INFECTION;

CHILD; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION;

EID: 67649410578     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0869-z     Document Type: Review

References (51)

1. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723
2. Isoniemi H, Taskinen E, Hayry P (1994) Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 58:1195-1198
3. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422
4. Fuecht H, Felber E, Gokel MJ, Hillerbrand G, Nattermann U, Brockmeyer C, Held E, Riethmuller G, Land W, Albert E (1991) Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 86:464-470
5. Nickeleitt V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ (2002) Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 13:242-251
6. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka JM, Cosyns JP, Demetris AJ, Fishbein MC, Fogo AB, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern LG, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K (2003) Antibody mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3:708-714
7. Herman J, Lerut E, Damme-Lombaerts R, Emonds MP, Van Damme B (2005) Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation 79:1435-1440
8. Tejani A, Cortes L, Stablein D (1996) Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 61:1054-1058
9. Fernando GC, Griffin MD, Grande J, Lager DJ, Gloor JM, Velosa JA, Larson TS, Stegall MD (2004) Development of chronic allograft nephropathy (CAN) in low risk kidney transplant recipients. Am J Transplant 4:278
10. Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, Claesson K, Castagneto M, Campistol JM, Hutchison B, Burke JT, Yilmaz S, Hayry P, Neylan JF (2004) Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 4:953-961
11. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349:2326-2333
12. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD (2004) Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 78:557-565
13. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR (2004) Evolution and pathophysiology of renal-transplant glomerulosclerosis. Transplantation 78:461-468
14. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD (2004) Delta analysis of posttransplantation tubulointerstitial damage. Transplantation 78:434-441
15. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR (2004) Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 78:242-249
16. Schwarz A, Mengel M, Gwinner W, Radermarcher J, Hiss-Kreipe H, Haller H (2005) Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 67:341-348
17. Benamenyo JP, Droz D, Niaudet P (2001) One-year routine renal transplant biopsies in children. Pediatr Nephrol 6:971-977
18. Birk PE, Stannard KM, Konrad HB, Blydt-Hansen TD, Ogborn MR, Cheang MS, Gartner JG, Gibson IW (2004) Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant 8:29-38
19. Fujisawa M, Ono H, Isotani S, Higuchi A, Iijima K, Yoshiya K, Arakawa S, Matsumoto O, Nakamura H, Kamidono S, Yoshikawa N (1999) Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation. Transplant Proc 31:1687-1690
20. Naesens M, Kambham N, Concepcion W, Salvatierra O Jr. Sarwal M (2007) The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant 7:2504-2514
21. Qvist E, Krogerus L, Ronnholm K, Laine J, Jalanko H, Holmberg C (2000) Course of renal allograft histopathology after transplantation in early childhood. Transplantation 70:480-487
22. Shishido S, Asanuma H, Nakai H, Mori Y, Satoh H, Kamimaki I, Hataya H, Ideda M, Honda M, Hasegawa A (2003) The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 14:1046-1052
23. Harmon W, Meyers K, Ingelfinger JR, McDonald R, McIntosh MJ, Ho M, Spaneas LD, Palmer JA, Hawk M, Geehan C, Tinckam K, Hancock WW, Sayegh MH (2006) Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J Am Soc Nephrol 17:1735-1745
24. LaRosa D, Rahman A, Turka L (2007) The innate immune system in allograft rejection and tolerance. J Immunol 178:7503-7509
25. Zou Y, Stastny P, Susal C, Dohler B, Opelz G (2007) Antibodies against MICA antigens and kidney transplant rejection. N Engl J Med 357:1298-1300
26. Segundo D, Ruiz J, Izquierdo M, Fernandez-Fresnedo G, Gomez-Alamillo C, Merino R, Benito M, Cacho E, Rodrigo E, Palomar R, Lopez-Hoyos M, Arias M (2006) Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 82:550-557
27. Zeiser R, Nguyen V, Beilhack A, Buess M, Schulz S, Baker J, Contag C, Negrin R (2006) Inhibition of CD4+CD25+ regulatory T cell function by calcineurin-dependent interleukin-2 production. Blood 108:390-399
28. Brown K, Moxham V, Karegli J, Phillips R, Sacks S, Wong W (2007) Ultra-localisation of Foxp3+T cells within renal allografts shows infiltration of tubules mimmicking rejection. Am J Pathol 171:1915-1922
29. Smith JM, Ho PL, McDonald RA (2002) Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 6:493-499
30. Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, Tryggvason K, Jalanko H (2002) Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the finnish type- role of nephrin. Transplantation 73:394-403
31. Gallagher MP, Hall B, Craig J, Berry G, Tiller DJ, Eris J (2004) A randomized controlled trial of cyclosporine withdrawal in renal-transplant recipients: 15-year results. Transplantation 78:1653-1660
32. Harris S, Coupes B, Roberts S, Roberts I, Short C, Brenchley P (2007) TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol 20:177-185
33. Plank C, Benz K, Amann K, Nusken K, Dittrich K, Rascher W, Sauerstein K, Stuppy A, Klare B, Dotsch J (2006) Stable graft function after reduction of calcineurin inhibitor dosage in pediatric kidney transplant patients. Nephrol Dial Transplant 21:2930-2937
34. Powell HR, Kara T, Jones CL (2007) Early experience with conversion to sirolimus in a pediatric renal transplant population. Pediatr Nephrol 22:1773-1777
35. David-Neto E, Araujo LMP, Lemos FC, David DSR, Mazzucchi E, Nahas WC, Arap S, Ianhez LE (2001) Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy. Pediatr Transplant 5:302-309
36. Henne T, Latta K, Strehlau J, Ehrich JH, Offner G (2003) Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy. Transplantation 76:1326-1330
37. Kerecuk L, Taylor J, Clark G (2005) Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients. Pediatr Nephrol 20:1630-1635
38. Dharnidharka VR, Stablein DM, Harmon WE (2004) Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 4:384-389
39. Howell D, Smith S, Butterly D, Klassen P, Krigman H, Burchette J, Miller S (1999) Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 68:1279-1288
40. Oertel SH, Anagnostopoulos I, Bechstein WO, Liehr H, Riess HB (2000) Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: A new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation? Transplantation 69:430-432
41. Hsu DT (2005) Biological and psychological differences in the child and adolescent transplant recipient. Pediatr Transplant 9:416-421
42. Seikku P, Krogerus L, Jalanko H, Holmberg C (2005) Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children. Pediatr Transplant 9:754-762
43. Shapiro R, Starzl TE (2008) Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients. Pediatr Transplant 10:766-767
44. Grimm P (2004) The protocol renal allograft biopsy: Has its time come? Pediatr Transplant 8:3-5
45. Miyagi M, Ishikawa Y, Mizuiri S, Aikawa A, Ohara T, Hasegawa A (2005) Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction. Clin Transplant 19:456-465
46. Kee T, Chapman JR, O'Connell PJ, Fung C, Allen RD, Kable K, Vitalone M, Nankivell BJ (2006) Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 82:36-42
47. Rush D, Nickerson P, Gough J, McKenna R, Grimm P, Cheang M, Trpkov K, Solez K, Jeffery J (1998) Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 9:2129-2134
48. Rush DN, Karpinski ME, Nickerson P, Dancea S, Birk P, Jeffery JR (1999) Does subclinical rejection contribute to chronic rejection in renal transplant patients? Clin Transplant 13:441-446
49. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk P, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm P, Haas M, Lerut L, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening J (2007) Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7:518-526
50. Mengel M, Sis B, Halloran PF (2007) SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 7:2221-2226
51. Alexander SI, Fletcher JT, Nankivell BJ (2007) Chronic allograft nephropathy in pediatric renal transplantation. Pediatr Nephrol 22:17-23